Fri.Nov 04, 2022

article thumbnail

Guaranteed’s Funding Nears $10M on Journey to Improve End-of-Life Care

MedCity News

Tech-enabled hospice provider Guaranteed recently closed a $6.5 million seed round, bringing its total funding to $9.25 million. Jessica McGlory founded the startup a year ago so that patients and their families can have more dignified and holistic end-of-life care experiences than what she and her father went through.

Patients 132
article thumbnail

Why blockchain is big pharma’s big focus

pharmaphorum

To address the supply chain vulnerabilities of the pharma industry, an innovative, collaborative blockchain-based system could help to keep track of drugs in transit and ensure they are stored in the correct conditions. The pace of technological advancement and focus in this area suggests that such a solution could be coming soon. While most supply chains were impacted by the Covid-19 pandemic, the demands it placed on pharmaceutical and medical supply chains were immense and underlined the impo

Pharma 121
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AHA: 78% of Hospitals Say Experience With Commercial Insurers Is Worsening

MedCity News

Less than 1% of hospitals and health systems said their relationship is improving and the rest said it has stayed the same. The American Hospital Association specifically called out commercial insurers for their practices on prior authorization and claims denials and delays.

Insurance 122
article thumbnail

What can Rishi Sunak do for the UK’s pharma industry

Pharmaceutical Technology

Last week, after a tumultuous 45 days under Liz Truss’s control , the role of the UK’s Prime Minister (PM) was passed on to Rishi Sunak , in a bid to restore balance to the British economy. During her short reign, Truss’s cabinet had promised a £45 billion ($51.59 billion) mini-budget that included unfunded tax cuts for the rich, enacted a U-turn on an energy price freeze, and oversaw the largest drop in value for the British pound against the US dollar.

Pharma 93
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

For Neuro Biotech Lusaris, Depression Therapy Starts by Lifting the Tongue

MedCity News

Lusaris Therapeutics launched with $60 million for clinical development of a psychedelic depression drug it claims will be easier to dose and fast-acting. The company was formed and incubated by RA Capital Management, which led the startup’s Series A round of financing.

article thumbnail

Psilocybin improves depression symptoms, study shows

European Pharmaceutical Review

A new report in the New England Journal of Medicine for the largest-ever trial observing the effects of psilocybin in patients with treatment-resistant depression, found participants reported reduced depressive symptoms three weeks after being given 25mg of psilocybin (COMP360) in combination with psychological support. The multi-centre, Phase IIb trial observed the severity of depression in 233 individuals over 12 weeks in 22 sites and 10 countries across Europe (Czech Republic, Denmark, German

More Trending

article thumbnail

Court Block Penguin Random House Acquisition of Simon & Schuster

Copyright Clearance Center

The post Court Block Penguin Random House Acquisition of Simon & Schuster appeared first on Copyright Clearance Center.

98
article thumbnail

Homecare & Health Equity: The Rx for Reaching Underserved Populations

MedCity News

Empowering a high-quality homecare workforce with the skills and technologies they need is just the prescription the nation needs to address the health inequities that have been plaguing our underserved populations.

article thumbnail

Solving the taxing problems of taxanes?

European Pharmaceutical Review

Despite advances with targeted and immuno-oncology therapies, chemotherapies remain a cornerstone of cancer treatment for many tumour types – a reflection of their significant anti?tumour effects. Nevertheless, chemotherapy’s disadvantages, including substantial toxicities, combined with inconvenient hospital-based intravenous (IV) administration, impede patients’ ability to stay on treatment and their quality of life.

article thumbnail

Adding Accessibility Features to Digital Health Technologies: Enhancing Inclusion and the Patient Experience

MedCity News

A clinical trial population should mimic the patient population that will ultimately use the therapy […].

Patients 112
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Digital cognitive behaviour therapies recommended by NICE across the NHS

PharmaTimes

Treatment will assist young people and children with symptoms of mild-to-moderate anxiety

122
122
article thumbnail

Here Are 3 Ways Health Plans Can Avoid Member Abrasion

MedCity News

Healthcare is very personal, and consumers expect health plans to treat it that way. If […].

article thumbnail

The other ‘D’ in DE&I

PharmaVoice

How companies can work to include people with disabilities into broader equity aims.

98
article thumbnail

Leva Clinic fundraises £3m for UK’s first digital chronic pain platform

PharmaTimes

Funding will be used to broaden partnerships with the NHS and improve patient experience

Patients 101
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

StartUPDATES: New Developments for Healthcare Startups

MedCity News

Check out new developments from Carrum Health, Strive Health, Abridge and Concerto Biosciences.

article thumbnail

Unlocking the full power of data for Pharma

pharmaphorum

The value of data has never been greater in healthcare. With greater digital engagement and opportunities available as the world emerges from the COVID-19 pandemic, putting data to use is critical for healthcare and the pharmaceutical industry. In an increasingly digital-first world, the way that HCPs engage with organisations, conduct research, and search for information is changing.

Pharma 57
article thumbnail

Ipca Laboratories Ltd- Openings for Trainee/ Officer/ Sr. Officer in IT/ Warehouse Dept. -Apply Now

Pharma Pathway

Ipca Laboratories Ltd- Openings for Trainee/ Officer/ Sr. Officer in IT/ Warehouse Dept. -Apply Now. Job Description. Ipca Laboratories Ltd- Openings for Trainee/ Officer/ Sr. Officer in IT/ Warehouse Dept. -Apply Now. Department: IT/ Warehouse. Posts: Trainee/ Officer/ Sr. Officer. Qualification: B.Tech/ IT/ Diploma/ D.Pharm. Experience: 02-04 years / Freshers.

52
article thumbnail

Boehringer recruits former Novartis’ neurosciences head as its CMO

pharmaphorum

Boehringer Ingelheim has appointed Lykke Hinsch Gylvin as its new head of medicine and chief medical officer, succeeding Mehdi Shahidi, who left the position earlier this year after three years in the role. Hinsch Gylvin – who joins Boehringer after two years at Novartis, where she was firstly medical head of ophthalmology and latterly medical head of neurosciences – started in the new position on 1 November. “It’s so exciting to be part of this company as we share our passion to del

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Aishwarya Healthcare – Urgent requirements for Accounts / HR/QC/  Departments -Apply Now

Pharma Pathway

Aishwarya Healthcare – Urgent requirements for Accounts / HR/QC/ Departments -Apply Now. Job Description. Opening for Accounts / HR/QC/ Departments @ Aishwarya healthcare . Job Posted Date: 04/11 /2022. Last Date: 10/11/ 2022. Accounts department – Job opening for Manager/ Assistant Manager /Sr.Executive/ Executive with 5 to 13 years of experience in Cost accounts, Sales & Distribution Accounting, Corporate banking.

article thumbnail

Reaction Biology to acquire Vyant Bio subsidiary’s operations in US

Pharmaceutical Technology

Reaction Biology (Reaction) has concluded a definitive agreement for the acquisition of the US operations of Vyant Bio subsidiary, vivoPharm. The operations of vivoPharm are based in Hershey, Pennsylvania. According to the deal, Reaction made an upfront cash payment of $5.5m at closing. Vyant Bio anticipates receiving nearly $4.4m in cash after tax and deal-linked costs, as well as incur $0.6m in exit expenses.

article thumbnail

Galapagos’ new CEO Paul Stoffels wields axe in bid to go ‘forward, faster’

pharmaphorum

When long-serving Johnson & Johnson R&D chief Paul Stoffels cut short his retirement to take the helm at Galapagos earlier this year, it was clear he faced a challenge to steer the troubled Belgian biotech back on course. Several months later, and Stoffels (pictured above) has charted the way ahead under a new strategy he calls ‘forward, faster’, which includes shedding around 200 people from Galapagos’ total headcount of around 1,300 to conserve cash while the restruct

article thumbnail

From agility to AI: Safeguarding against supply chain disruptions

Pharmaceutical Technology

Global supply chains are resilient, but we cannot always rely on them. This instability was brought into focus during the pandemic, and since then supply chain disruption has reached unprecedented levels. Up until that point, supply chains had proven themselves to be resilient and efficient. Goods were largely delivered on time, and at a low cost, benefitting both companies and consumers.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Let’s Not Sugar Coat It: HbA1c is the Imperfect Diabetes Diagnostic

Pharmacy Times

When diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.

64
article thumbnail

Amgen reports decline in Q3 2022 total revenues

Pharmaceutical Technology

Amgen has reported a 1% decline in total revenues to $6.65bn in the third quarter (Q3) of 2022 as against $6.7bn in the year-ago quarter. For the quarter, total product sales were recorded at $6.2bn, a 1% drop from $6.3bn in Q3 2021. The drop in global product sales led to the decline in total revenue for the third quarter of this year, the company noted.

Sales 52
article thumbnail

Relationship Between Psoriasis, Kidney Damage Remains Unclear

Pharmacy Times

Psoriasis and end-stage renal disease are believed to share multiple pathogenic pathways, including various cytokines, reactive oxygen species, and psoriasis medications.

Medical 55
article thumbnail

WHO grants prequalification for Sinovac’s varicella vaccine

Pharmaceutical Technology

The World Health Organization (WHO) has granted prequalification for Sinovac Biotech’s live attenuated varicella vaccine. With the latest development, the vaccine became the first Chinese varicella shot to be prequalified by the WHO. It is also the company's fourth vaccine to receive approval from the health agency. According to the data from a Phase III efficacy clinical trial, the seroconversion rate was found to be 97.1% in a group of children aged one to 12 years old who received the vaccine

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Respiratory Syncytial Virus Infection in the Pediatric Population

Pharmacy Times

Infection with RSV can take a variety of forms, ranging from a mild upper respiratory tract infection to severe, life-threatening acute respiratory failure.

57
article thumbnail

Healthtech: detecting early risks of diseases and optimising treatments

Pharmaceutical Technology

Healthtech has the potential to not only improve diagnostics but also transform treatments – particularly through personalising the delivery of healthcare plans, better known as precision medicine. The use of technology such as artificial intelligence (AI) and machine learning in healthcare is expanding the understanding of conditions and accelerating the development timelines for medical treatments.

article thumbnail

Expert Suggests That Pharmacists Should Learn More About Dialysis

Pharmacy Times

Education, awareness, and more training may help more pharmacists and kidney patients consider home dialysis as an effective treatment option, said an expert on November 4 at ASN Kidney Week in Orlando, Florida.

article thumbnail

Addressing the Knowledge Gap in Biologics & Biosimilars: Is a Board Certified Biologics and Biosimilars Program the Answer?

PharmExec

Life sciences professionals will need keep up with market demand for biologics and biosimilars.

article thumbnail

Clinical Supply Strategies for CROs

When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and ability to hit key milestones such as FPI for their client.